M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

FM 140 vs FM100 Study in Patients With Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Melphalan
Drug: Fludarabine
Procedure: Stem Cell Infusion
Drug: Rituximab

First Posted Date: 2007-07-25

Last Posted Date: 2014-10-17

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 52

Registration Number: NCT00505895

Locations: 🇺🇸
UT MD . Anderson Cancer Center, Houston, Texas, United States

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Phase 2

Completed

Conditions: Disorder Related to Bone Marrow Transplantation
Lymphoma

Interventions: Drug: Fludarabine
Drug: Melphalan
Procedure: Allogeneic Transplant
Drug: Thymoglobulin

First Posted Date: 2007-07-25

Last Posted Date: 2020-12-29

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 33

Registration Number: NCT00506129

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Etiology of Multiple Myeloma: A Case-Control Study

Conditions: Multiple Myeloma

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-25

Last Posted Date: 2020-01-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 140

Registration Number: NCT00505999

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Transition From Research to Disclosure in Human Genetics

Completed

Conditions: Education

Interventions: Behavioral: Genetic Counseling

First Posted Date: 2007-07-23

Last Posted Date: 2022-03-04

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 577

Registration Number: NCT00505466

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Biobehavioral Effects of Emotional Expression in Cancer

Not Applicable

Completed

Conditions: Kidney Cancer

Interventions: Behavioral: Writing
Behavioral: Questionnaire

First Posted Date: 2007-07-23

Last Posted Date: 2022-08-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 705

Registration Number: NCT00505310

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Biochemotherapy With Temozolomide for Metastatic Melanoma

Phase 2

Terminated

Conditions: Melanoma

Interventions: Drug: Temozolomide
Drug: Velban
Drug: Cisplatin
Drug: Interleukin-2
Drug: Intron-A
Drug: Thalidomide

First Posted Date: 2007-07-23

Last Posted Date: 2020-09-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 5

Registration Number: NCT00505635

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

New Assessment System in Measuring Symptom Distress in Cancer Patients

Recruiting

Conditions: Health Care Provider
Caregiver
Malignant Neoplasm
Physician

Interventions: Other: Interview
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2007-07-23

Last Posted Date: 2025-01-17

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 6500

Registration Number: NCT00505245

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Mifepristone for Patients With Endometrial Cancer and LGESS

Phase 2

Completed

Conditions: Endometrial Cancer

Interventions: Drug: Mifepristone

First Posted Date: 2007-07-23

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 13

Registration Number: NCT00505739

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy

Phase 2

Terminated

Conditions: Uterine Neoplasms

Interventions: Drug: Carboplatin
Drug: Cisplatin
Drug: Paclitaxel

First Posted Date: 2007-07-23

Last Posted Date: 2011-09-15

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 4

Registration Number: NCT00505492

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
University of Washington School of Medicine, Seattle, Washington, United States

Reflectance Confocal Imaging in Cervical Cancer Patients

Completed

Conditions: Cervical Cancer

Interventions: Procedure: Reflectance Confocal Imaging

First Posted Date: 2007-07-23

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 39

Registration Number: NCT00505726

Locations: 🇨🇦
British Columbia Cancer Research Center, Vancouver, British Columbia, Canada
🇺🇸
U. T. Health Science Center, Houston, Texas, United States
🇺🇸
Lyndon B. Johnson Hospital, Houston, Texas, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy